Dopamine agonists and Othello’s syndrome |
| |
Authors: | Jonathan Graff-Radford J. Eric Ahlskog James H. Bower Keith A. Josephs |
| |
Affiliation: | a Department of Neurology, Mayo Clinic, 200 1st Street S.W. Rochester, MN 55905, USA;b Division of Movement Disorders, Mayo Clinic, 200 1st Street S.W. Rochester, MN 55905, USA;c Division of Behavioral Neurology, Mayo Clinic, 200 1st Street S.W. Rochester, MN 55905, USA |
| |
Abstract: | BackgroundOthello’s syndrome (OS) is a delusion of infidelity. We describe seven cases of OS in Parkinson’s disease (iPD) patients using dopamine agonists.MethodsWe searched the Mayo Clinic Medical Records System to identify all patients with OS. Clinical data abstracted include sex, age of onset of iPD, age of onset of OS, medications, effect of discontinuing the dopamine agonist, neuroimaging, and comorbidities.ResultsSeven non-demented iPD patients with dopamine agonist implementation time locked to the development and resolution of OS are reported. The average age of iPD onset was 46.6 years (Standard deviation: 5.0 years), and OS onset was 53.7 years (7.1 years). All seven patients had significant marital conflict as a result of the delusions. Conclusions: OS can be associated with dopamine agonist use and can lead to serious consequences. Dopamine agonist cessation eliminates the delusion of infidelity and should be the first treatment option. |
| |
Keywords: | Dopamine Othello’ s syndrome Parkinson’ s disease Delusion |
本文献已被 ScienceDirect 等数据库收录! |
|